VERWENDUNG VON IN DER MITTLEREN ODER SPÄTEN FOLLIKULÄREN PHASE VERABREICHTEN LH ZUR BEHANDLUNG VON ANOVULATORISCHEN FRAUEN

摘要

The present invention relates to the use of gonadotrophins in the induction of folliculogenesis in anovulatory women. In particular, it relates to the use of LH (or an equivalent dosage of hCG) in the production of a medicament for inducing folliculogenesis in anovulatory women at a specified daily doses. In certain embodiments, LH may be used in conjunction with FSH.